PPARG and prostate carcinoma: Type 2 diabetes risk alleles in PPARG (encoding peroxisome proliferator-activated receptor γ [PPARγ]) [23, 24] and HNF1B (encoding hepatocyte nuclear factor 1 homeobox B) [25] lower the risk of prostate cancer.